Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) has been assigned a consensus rating of “Hold” from the twenty brokerages that are presently covering the firm, MarketBeat Ratings reports. Thirteen investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $11.81.
A number of brokerages have commented on TDOC. Bank of America boosted their price target on shares of Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research note on Wednesday, February 12th. Piper Sandler reissued an “overweight” rating and set a $13.00 target price (up from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. Oppenheimer dropped their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. Barclays lifted their price target on Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. Finally, The Goldman Sachs Group increased their price objective on Teladoc Health from $14.00 to $16.00 and gave the stock a “buy” rating in a research note on Tuesday.
View Our Latest Analysis on TDOC
Insider Buying and Selling
Institutional Investors Weigh In On Teladoc Health
Several institutional investors have recently added to or reduced their stakes in the business. Arizona State Retirement System raised its position in shares of Teladoc Health by 1.8% in the fourth quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider’s stock valued at $452,000 after purchasing an additional 859 shares during the period. Mercer Global Advisors Inc. ADV grew its stake in Teladoc Health by 9.6% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider’s stock valued at $113,000 after buying an additional 1,089 shares in the last quarter. Canada Pension Plan Investment Board raised its holdings in Teladoc Health by 0.5% during the 4th quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider’s stock valued at $2,079,000 after acquiring an additional 1,200 shares during the period. Summit Investment Advisors Inc. lifted its position in shares of Teladoc Health by 8.0% during the fourth quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider’s stock worth $164,000 after acquiring an additional 1,331 shares in the last quarter. Finally, Vise Technologies Inc. boosted its holdings in shares of Teladoc Health by 4.9% in the fourth quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock worth $274,000 after acquiring an additional 1,405 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.
Teladoc Health Price Performance
Shares of NYSE:TDOC opened at $12.75 on Friday. Teladoc Health has a twelve month low of $6.76 and a twelve month high of $16.82. The stock’s 50 day moving average is $10.52 and its 200-day moving average is $9.41. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $2.19 billion, a price-to-earnings ratio of -2.21 and a beta of 1.05.
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
- Five stocks we like better than Teladoc Health
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- What Investors Need to Know to Beat the Market
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.